Assessment and Management of Adenoidal Hypertrophy in a 5-Year-Old
Screen for obstructive sleep-disordered breathing (oSDB) symptoms and perform a focused clinical assessment; if symptoms of obstructive sleep apnea (OSA) are present, adenotonsillectomy is the first-line treatment, but adenoidectomy alone should only be performed when a distinct indication exists beyond simple adenoid enlargement.
Clinical Assessment
History - Key Elements to Elicit
Focus your questioning on these specific symptoms 1:
- Nighttime symptoms: Snoring (frequency ≥3 times/week), witnessed apneas, restless sleep, noisy breathing during sleep
- Daytime symptoms: Mouth breathing, chronic nasal obstruction, recurrent rhinosinusitis, chronic adenoiditis
- Associated problems: Recurrent throat infections, otitis media with effusion (OME), behavioral issues, hyperactivity, poor school performance
- Growth concerns: Failure to thrive or suboptimal growth
- Nocturnal enuresis (after at least 6 months of continence)
A clinical scoring system can be helpful: difficulty breathing during sleep + apnea + snoring correlates well with severity 2, 3.
Physical Examination - Specific Findings
- Ear examination: Otoscopy with pneumatic otoscopy or tympanometry to detect middle ear effusion 4
- Oropharyngeal inspection: Assess tonsillar size (note: adenoid size alone does NOT predict obstruction severity)
- Nasal examination: Assess for mouth breathing, nasal patency
- Facial features: Look for adenoid facies, mandibular retrognathia (especially important at this age as craniofacial changes begin appearing between 5-8 years) 5
Diagnostic Testing
For suspected OSA: Polysomnography (PSG) is the gold standard and should be performed when symptoms suggest OSA 1. If PSG is unavailable, alternative diagnostic tests or specialist referral is appropriate 1.
For suspected OME: Audiometry and tympanometry are mandatory to document hearing loss 4, 6.
Imaging considerations: Lateral neck radiography has poor correlation with clinical symptoms 2. Nasal endoscopy is the gold standard for directly visualizing adenoid obstruction 7, but clinical assessment alone can guide management when endoscopy is unavailable 2.
Management Algorithm
If OSA is Documented or Strongly Suspected
Adenotonsillectomy is recommended as first-line treatment 1. This is critical because:
- At age 5, the child is in a key developmental window where untreated OSA causes neurocognitive deficits, behavioral problems, growth impairment, and craniofacial changes 1, 5
- Adenotonsillectomy effectively treats OSA with improvements in symptoms, quality of life, behavior, attention, and growth 1
Important caveat: If adenotonsillar hypertrophy is present, remove both adenoids AND tonsils—adenoidectomy or tonsillectomy alone may be insufficient 1.
If OME is Present (Without OSA)
At age 5, the management depends on duration and hearing status 6, 4:
For OME <3 months: Watchful waiting with surveillance every 3-6 months 6
For OME ≥3-4 months with hearing loss:
- First surgery: Tympanostomy tubes are preferred 6, 4
- Adenoidectomy should NOT be performed unless distinct indications exist: nasal obstruction, chronic adenoiditis, or chronic sinusitis 4
For repeat surgery (if OME recurs after tubes): Adenoidectomy PLUS myringotomy ± tubes is recommended, as adenoidectomy reduces future surgery needs by 50% and is most beneficial at age ≥4 years 6, 4
If Isolated Adenoid Hypertrophy (No OSA, No OME)
Medical management first 7, 8:
- Intranasal corticosteroids (e.g., mometasone furoate) show short-term effectiveness
- Combined therapy with nasal saline irrigation can be attempted
- 72% of preschool children show clinical improvement with maximal medical treatment 8
Surgery (adenoidectomy) is reserved for:
- Treatment failure after medical management
- Severe nasal obstruction
- Chronic adenoiditis
- Recurrent rhinosinusitis refractory to medical treatment
Critical Pitfalls to Avoid
Don't perform adenoidectomy for OME in a child <4 years old unless distinct indications exist beyond the effusion itself 6, 4. The surgical risks outweigh benefits at this age for OME alone.
Don't rely on adenoid size alone: Adenoid size does NOT correlate with symptom severity 4. A child with small adenoids can have significant OSA, and vice versa.
Don't miss OSA: Caregiver reports of snoring/apnea are unreliable if they don't observe the child during the second half of the night when REM sleep predominates 9. Consider PSG even with mild reported symptoms if tonsils are markedly enlarged.
Don't perform tonsillectomy alone for OME: It's ineffective with hemorrhage risk (~2%) that outweighs any benefit 4.
Don't delay intervention if OSA is present: At age 5, untreated OSA causes measurable IQ loss, behavioral problems, and craniofacial changes that worsen with age 1, 5, 10.
Postoperative Considerations
If surgery is performed, reevaluate postoperatively to determine if further treatment is needed 1. High-risk patients (age <3 years, severe OSA on PSG, obesity, craniofacial abnormalities, neuromuscular disorders) require inpatient monitoring 1.